Characteristics of 228 stem cell transplant recipients with parainfluenza virus-3 infection
. | PIV-3 (N = 222) N (%) . | No PIV-3 (N = 3355) N (%) . |
---|---|---|
Median age in y (range) | 37.7 (0.6-67) | 38.7 (0.3-68.3) |
Gender | ||
Female | 93 (42) | 1547 (46) |
Male | 129 (58) | 1808 (54) |
Underlying disease | ||
Acute leukemia | 78 (35) | 1011 (30) |
Chronic myelogenous leukemia | 64 (29) | 918 (27) |
Non-Hodgkin lymphoma/Hodgkin disease/multiple myeloma | 32 (14) | 557 (17) |
Myelodysplasia | 14 (6) | 281 (8) |
Solid malignancy | 11 (5) | 242 (7) |
Nonmalignant diseases | 23 (10) | 346 (10) |
Disease risk | ||
Nonadvanced | 148 (67) | 1155 (66) |
Advanced | 74 (33) | 2200 (34) |
CMV serostatus | ||
D+/R+ | 51 (29) | 710 (28) |
D+/R− | 24 (14) | 371 (15) |
D−/R+ | 40 (23) | 594 (23) |
D−/R− | 62 (35) | 838 (33) |
Autologous R+ | 29 (64) | 447 (55) |
Donor type | ||
Matched sibling | 71 (32) | 1191 (35) |
Mismatched/nonsibling related | 26 (12) | 361 (11) |
Unrelated | 80 (36) | 985 (29) |
Autologous | 45 (20) | 818 (24) |
. | PIV-3 (N = 222) N (%) . | No PIV-3 (N = 3355) N (%) . |
---|---|---|
Median age in y (range) | 37.7 (0.6-67) | 38.7 (0.3-68.3) |
Gender | ||
Female | 93 (42) | 1547 (46) |
Male | 129 (58) | 1808 (54) |
Underlying disease | ||
Acute leukemia | 78 (35) | 1011 (30) |
Chronic myelogenous leukemia | 64 (29) | 918 (27) |
Non-Hodgkin lymphoma/Hodgkin disease/multiple myeloma | 32 (14) | 557 (17) |
Myelodysplasia | 14 (6) | 281 (8) |
Solid malignancy | 11 (5) | 242 (7) |
Nonmalignant diseases | 23 (10) | 346 (10) |
Disease risk | ||
Nonadvanced | 148 (67) | 1155 (66) |
Advanced | 74 (33) | 2200 (34) |
CMV serostatus | ||
D+/R+ | 51 (29) | 710 (28) |
D+/R− | 24 (14) | 371 (15) |
D−/R+ | 40 (23) | 594 (23) |
D−/R− | 62 (35) | 838 (33) |
Autologous R+ | 29 (64) | 447 (55) |
Donor type | ||
Matched sibling | 71 (32) | 1191 (35) |
Mismatched/nonsibling related | 26 (12) | 361 (11) |
Unrelated | 80 (36) | 985 (29) |
Autologous | 45 (20) | 818 (24) |
CMV indicates cytomegalovirus; PIV-3, parainfluenza virus-3.